|
Survived during observation period (n = 183)
|
2.11
|
(1.71, 2.61)
|
<0.0001
|
|
Hospitalized during ART (n = 20)
|
1.50
|
(1.13, 2.01)
|
0.0052
|
|
ART changed due to side effects (n = 27)
|
1.40
|
(1.09, 1.79)
|
0.0083
|
|
Weight above lowest quartile at baseline (n = 155)
|
1.25
|
(1.03, 1.52)
|
0.0244
|
|
Fewer than 5 symptoms at ART initiation (n = 147)
|
1.22
|
(1.03, 1.46)
|
0.0238
|
|
Physician time
|
Relative difference
|
95% CI
|
p-value
|
|
ART changed due to side effects or failure (n = 27)
|
1.62
|
(1.34, 1.97)
|
<0.0001
|
|
Survived during observation period (n = 183)
|
1.59
|
(2.18, 3.78)
|
<0.0001
|
|
Treated for TB (n = 33)
|
1.58
|
(1.32, 1.88)
|
<0.0001
|
|
Female gender (n = 122)
|
1.22
|
(1.07, 1.39)
|
0.0040
|
|
No Income (n = 125)
|
1.20
|
(1.05, 1.37)
|
0.0089
|
|
Nurse time
|
Relative difference
|
95% CI
|
p-value
|
|
Treated for TB (n = 33)
|
1.56
|
(1.27, 1.90)
|
<0.0001
|
|
Survived during observation period (n = 183)
|
2.13
|
(1.68, 2.70)
|
<0.0001
|
